BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14680832)

  • 1. Function of fibrinogen gamma-chain dodecapeptide-conjugated latex beads under flow.
    Takeoka S; Okamura Y; Teramura Y; Watanabe N; Suzuki H; Tsuchida E; Handa M; Ikeda Y
    Biochem Biophys Res Commun; 2003 Dec; 312(3):773-9. PubMed ID: 14680832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemostatic effects of fibrinogen gamma-chain dodecapeptide-conjugated polymerized albumin particles in vitro and in vivo.
    Okamura Y; Takeoka S; Teramura Y; Maruyama H; Tsuchida E; Handa M; Ikeda Y
    Transfusion; 2005 Jul; 45(7):1221-8. PubMed ID: 15987370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New strategy of platelet substitutes for enhancing platelet aggregation at high shear rates: cooperative effects of a mixed system of fibrinogen gamma-chain dodecapeptide- or glycoprotein Ibalpha-conjugated latex beads under flow conditions.
    Okamura Y; Handa M; Suzuki H; Ikeda Y; Takeoka S
    J Artif Organs; 2006; 9(4):251-8. PubMed ID: 17171404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel platelet substitutes: disk-shaped biodegradable nanosheets and their enhanced effects on platelet aggregation.
    Okamura Y; Fukui Y; Kabata K; Suzuki H; Handa M; Ikeda Y; Takeoka S
    Bioconjug Chem; 2009 Oct; 20(10):1958-65. PubMed ID: 19788180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrastructural analysis of thrombin-induced interaction between human platelets and liposomes carrying fibrinogen γ-chain dodecapeptide as a synthetic platelet substitute.
    Suzuki H; Okamura Y; Ikeda Y; Takeoka S; Handa M
    Thromb Res; 2011 Dec; 128(6):552-9. PubMed ID: 21840573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemostatic effects of phospholipid vesicles carrying fibrinogen gamma chain dodecapeptide in vitro and in vivo.
    Okamura Y; Maekawa I; Teramura Y; Maruyama H; Handa M; Ikeda Y; Takeoka S
    Bioconjug Chem; 2005; 16(6):1589-96. PubMed ID: 16287259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemostatic effects of polymerized albumin particles carrying fibrinogen gamma-chain dodecapeptide as platelet substitutes in severely thrombocytopenic rabbits.
    Okamura Y; Fujie T; Nogawa M; Maruyama H; Handa M; Ikeda Y; Takeoka S
    Transfus Med; 2008 Jun; 18(3):158-66. PubMed ID: 18598278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fibrinogen gamma chain dodecapeptide inhibits agonist-induced aggregation of rabbit platelets and fibrinogen binding to rabbit glycoprotein IIb-IIIa.
    Rand ML; Packham MA; Taylor DM; Yeo EL; Gemmell CH; Patil S; Lam SC
    Thromb Haemost; 1999 Dec; 82(6):1680-6. PubMed ID: 10613655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of platelets with Synthocytes, a novel platelet substitute.
    Davies AR; Judge HM; May JA; Glenn JR; Heptinstall S
    Platelets; 2002 Jun; 13(4):197-205. PubMed ID: 12189020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged hemostatic ability of polyethylene glycol-modified polymerized albumin particles carrying fibrinogen gamma-chain dodecapeptide.
    Okamura Y; Fujie T; Maruyama H; Handa M; Ikeda Y; Takeoka S
    Transfusion; 2007 Jul; 47(7):1254-62. PubMed ID: 17581161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ability of fibrinogen γ-derived dodecapeptides with different sequences to bind to rat platelets.
    Tokutomi K; Tagawa T; Korenaga M; Chiba M; Asai T; Watanabe N; Takeoka S; Handa M; Ikeda Y; Oku N
    Int J Pharm; 2012 Nov; 438(1-2):296-301. PubMed ID: 22985603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The AGDV residues on the gamma chain carboxyl terminus of platelet-bound fibrinogen are needed for platelet aggregation.
    Liu Q; Matsueda G; Brown E; Frojmovic M
    Biochim Biophys Acta; 1997 Dec; 1343(2):316-26. PubMed ID: 9434121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release abilities of adenosine diphosphate from phospholipid vesicles with different membrane properties and their hemostatic effects as a platelet substitute.
    Okamura Y; Katsuno S; Suzuki H; Maruyama H; Handa M; Ikeda Y; Takeoka S
    J Control Release; 2010 Dec; 148(3):373-9. PubMed ID: 20875473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variations in the ability of adsorbed fibrinogen to mediate platelet adhesion to polystyrene-based materials: a multivariate statistical analysis of antibody binding to the platelet binding sites of fibrinogen.
    Tsai WB; Grunkemeier JM; Horbett TA
    J Biomed Mater Res A; 2003 Dec; 67(4):1255-68. PubMed ID: 14624512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the role of adjacent amino acids to the 313-320 sequence of the alphaIIb subunit on platelet activation and fibrinogen binding to alphaIIbbeta3.
    Mitsios JV; Stamos G; Rodis FI; Tsironis LD; Stanica MR; Sakarellos C; Tsoukatos D; Tsikaris V; Tselepis AD
    Platelets; 2006 Aug; 17(5):277-82. PubMed ID: 16928597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic study of the structural components of adenosine diphosphate-encapsulated liposomes coated with fibrinogen γ-chain dodecapeptide as a synthetic platelet substitute.
    Taguchi K; Ujihira H; Ogaki S; Watanabe H; Fujiyama A; Doi M; Okamura Y; Takeoka S; Ikeda Y; Handa M; Otagiri M; Maruyama T
    Drug Metab Dispos; 2013 Aug; 41(8):1584-91. PubMed ID: 23735758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of single-walled carbon nanotubes on the functions of plasma proteins and potentials in vascular prostheses.
    Meng J; Song L; Xu H; Kong H; Wang C; Guo X; Xie S
    Nanomedicine; 2005 Jun; 1(2):136-42. PubMed ID: 17292070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinogen-coated albumin microcapsules reduce bleeding in severely thrombocytopenic rabbits.
    Levi M; Friederich PW; Middleton S; de Groot PG; Wu YP; Harris R; Biemond BJ; Heijnen HF; Levin J; ten Cate JW
    Nat Med; 1999 Jan; 5(1):107-11. PubMed ID: 9883848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic study of adenosine diphosphate-encapsulated liposomes coated with fibrinogen γ-chain dodecapeptide as a synthetic platelet substitute in an anticancer drug-induced thrombocytopenia rat model.
    Taguchi K; Ujihira H; Watanabe H; Fujiyama A; Doi M; Takeoka S; Ikeda Y; Handa M; Otagiri M; Maruyama T
    J Pharm Sci; 2013 Oct; 102(10):3852-9. PubMed ID: 23918456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of platelet aggregation and aminophospholipid exposure by calpain.
    Bachelot-Loza C; Badol P; Brohard-Bohn B; Fraiz N; Cano E; Rendu F
    Br J Haematol; 2006 May; 133(4):419-26. PubMed ID: 16643450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.